ICICI Lombard General Insurance Company / Q3-FY26

ICICIGI Q3 FY26 earnings call.

A source-linked concall view: reported numbers, management language, guidance, commitments and risks that should carry forward.

Research layer active

ConCallIQ research layer

Signal, with the source still visible.

Use the controls below to narrow the view, then follow the evidence into the next layer of context.

Positive2026-01-20Back to ICICIGI

Revenue

Pending

verification pending

Revenue YoY

reported change

EBITDA

Pending

latest reported figure

Source

manual review required

record provenance

Actual signal trajectory

Where this quarter sits.

source records only
PAT (₹ Cr)PositiveWatchNegative
2 actual records
Actual quarterly PAT (₹ Cr) trajectoryReported values plotted by quarter. Hover or focus a point for its quarter, value, and source sentiment.Q2 FY26: 820 · Positive source sentiment · 2025-10-23Q2 FY26Q1 FY27: 403 · Watch source sentimentQ1 FY27820403
Values are taken from the available verified source records; sentiment color is a separate source-read indicator.

Quarter read

What the record says.

ICICI Lombard reported a strong Q3 FY26 with GDPI growth of 13.3% YoY, outperforming the industry's 11.5%, driven by robust retail health (up 85.8%) and motor (up 9.3%) segments. The retail health market share rose to 4.5% from 3.2% a year ago, fueled by GST exemption tailwinds and new-to-industry customer growth of 1.7x. Motor growth rebounded to 9.3% in Q3 from 2.2% in H1, supported by festive demand and broad-based vehicle sales. The combined ratio on an N basis improved to 103.1% (Q3 FY26) from 102.3% (Q3 FY25), excluding a one-time wage code impact of ₹55 crore. Management expects to sustain 100-200 bps growth outperformance vs industry and maintain ROE in the 18-20% range. Key risk: sustained competitive intensity in motor could pressure pricing and margins.

Colored figures show movement against the previous available record.

Guidance to track

  • Management aims to grow 100-200 basis points above industry growth across all lines, as demonstrated in Q3.
  • Management targets sustaining ROE in the 18-20% range, with 9M FY26 ROE at ~19.5% on a 1-by-N basis.
  • Management expects combined ratio on an N basis to remain around 103% or better, excluding one-time items.

Risks flagged

  • Industry motor combined ratio worsened to 128.5% in H1 FY26 from 124.8% in H1 FY25, indicating sustained pricing pressure.
  • The one-time wage code impact of ₹55 crore includes ₹17 crore of unamortized cost to be spread over 3 years, with potential further regulatory changes.
  • As the retail health portfolio matures, loss ratios may increase from current levels (63-67%) over time, though management expects offset from lower acquisition costs.

Key quotes

  • We are very comfortable walking away what is not making basic sense on the RO level for motor.
  • The growth in retail health is broad-based across markets and supported by a surge in first-time buyers especially for tier 2 and tier three cities.
  • We have absolute clarity that even if it's long-term, what we will do is what comes with one-by as a team for us we continue to operate strictly on those guidelines.

Research modules

Go one layer deeper.